Log in to save to my catalogue

Alzheimer’s Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field

Alzheimer’s Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3800662

Alzheimer’s Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field

About this item

Full title

Alzheimer’s Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field

Publisher

Egypt: Hindawi Publishing Corporation

Journal title

ISRN neurology, 2013, Vol.2013, p.989583-9

Language

English

Formats

Publication information

Publisher

Egypt: Hindawi Publishing Corporation

Subjects

Subjects and topics

More information

Scope and Contents

Contents

This study was to investigate the feasibility of frequency doubling technology (FDT) visual field testing in Alzheimer’s disease (AD) in order to identify early biomarkers of AD in patients already diagnosed with AD and compare the findings to participants not having Alzheimer’s disease. This biomarker would be useful in a battery of tests for the...

Alternative Titles

Full title

Alzheimer’s Disease: Screening Biomarkers Using Frequency Doubling Technology Visual Field

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3800662

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3800662

Other Identifiers

ISSN

2090-5505,2090-5513

E-ISSN

2090-5513

DOI

10.1155/2013/989583

How to access this item